Blue Prism has appointed Ian Horobin as its Chief Product Officer.
The new role aligns R&D, product management and marketing at the Warrington-headquartered robotic process automation giant.
Horobin has extensive experience in AI, machine learning and data science.
“Ian brings a wealth of experience as a serial tech entrepreneur to Blue Prism,” says Jason Kingdon, Executive Chairman of Blue Prism.
“His expertise in pioneering leading-edge technologies and bringing them to market will be an asset to our team.
“I’m thrilled to have him in this strategic role that will drive our vision and product roadmap to deliver a Digital Workforce for Every Enterprise, transforming our customers’ businesses and the future of work.”
Horobin arrives from Rahko, where he continues to serve as Executive Chairman. The company is working to solve some of the world’s most complex problems by driving fundamental advances in chemistry, pharmaceuticals and materials design through quantum computing and machine learning.
Prior to Rahko, Horobin founded Omnicision, a provider of financial crime prevention services and solutions that was acquired by SWIFT in 2014.
He stayed on with SWIFT following the acquisition to build out the company’s innovation services, including data sciences. Before that, he led Searchspace product organisation—the company was a spinout from University College London that grew to become a world leader in systems to detect financial crime and comply with increasingly demanding regulatory standards.
“It is an exciting time to join Blue Prism, as the company is poised to bring new levels of technology and engineering excellence to bear to set us apart in the market,” said Horobin.
“Since engaging with the leadership and product teams, I’ve been impressed by their knowledge of the RPA market, and even more so by their passion for being an instrument of true transformational change for customers.”
Horobin is also a director of ConceptionX, an organization setup to help PHD students setup startups to commercialize their research.